GENS.F Stock Overview
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Genus plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£28.01 |
| 52 Week High | UK£28.35 |
| 52 Week Low | UK£26.79 |
| Beta | 0.32 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -59.64% |
| 5 Year Change | -3.91% |
| Change since IPO | 83.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| GENS.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -3.9% | -3.1% |
| 1Y | n/a | -1.8% | 20.9% |
Return vs Industry: Insufficient data to determine how GENS.F performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how GENS.F performed against the US Market.
Price Volatility
| GENS.F volatility | |
|---|---|
| GENS.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GENS.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GENS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 3,500 | JK Kokke | www.genusplc.com |
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Genus plc Fundamentals Summary
| GENS.F fundamental statistics | |
|---|---|
| Market cap | US$1.46b |
| Earnings (TTM) | US$42.15m |
| Revenue (TTM) | US$849.37m |
34.6x
P/E Ratio1.7x
P/S RatioIs GENS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GENS.F income statement (TTM) | |
|---|---|
| Revenue | UK£673.10m |
| Cost of Revenue | UK£429.10m |
| Gross Profit | UK£244.00m |
| Other Expenses | UK£210.60m |
| Earnings | UK£33.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 05, 2024
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 36.25% |
| Net Profit Margin | 4.96% |
| Debt/Equity Ratio | 40.7% |
How did GENS.F perform over the long term?
See historical performance and comparison